… from a particular drug or from adjuvant or perioperative therapy … Caris, and from the pharmaceutical industry. Not every … prospective randomized trial of adjuvant chemotherapy for stage Ia … colon cancer patients receiving adjuvant chemotherapy. J Clin Oncol …

… (orally administered tetrahydrocannabinol (THC)) as adjuvant therapy to first-line standard … Products (Phase II) APD403: Acacia Pharma Drug profiles in the detailed report …

… Nature found that 2 AS01-adjuvanted vaccines—Arexvy (RSVPreF3; GSK), the respiratory … that both the AS01-adjuvanted shingles and RSV vaccines related to a … the Arexvy RSV vaccine, which contains the same adjuvant, and found that …

… lead drug product, the amyloid-beta (Aß) vaccine, AV … validate decades of translational vaccine research and offer … is an adjuvanted, Aß epitope-specific vaccine built on … biotechnology company developing immunotherapy vaccines for neurodegenerative diseases …

… chemoradiation. To date, adjuvant nivolumab remains the only … treatment with the study drug [at the time of … with chemoradiation followed by adjuvant nivolumab, which is currently … neoadjuvant chemoradiation followed by adjuvant nivolumab, based on the …

Photo Credit: iStock.com/Mohammed Haneefa Nizamudeen Interim results from a randomized trial suggest an assay could refine treatment decisions for patients with stage Ia–IIa non-squamous NSCLC. An early interim analysis from a phase 3 trial suggests …

… Unlike conventional intramuscular vaccines, which primarily generate … may integrate emerging adjuvants to further … vaccine technologyCOVID-19 vaccine clinical trialinhaled COVID vaccinelocalized immune responselung mucosal immunitynext-generation vaccine …

Panelists discuss recent phase 3 trials of novel endocrine agents in advanced breast cancer, highlighting benefits—especially in patients with ESR1 mutations—from proteolysis-targeting chimeras (PROTACs) and oral selective estrogen receptor degraders ( …

… -muscle FDA approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced … ;www.fda.gov/drugs/;resources-information-approved-drugs/;fda-approves-neoadjuvant-and-adjuvant-pembrolizumab-resectable-locally-advanced-head …

… are potent mucosal adjuvants for influenza hemagglutinin vaccines. The influenza hemagglutinin … are potent mucosal adjuvants for influenza hemagglutinin vaccines,” said Bao- … represent a promising adjuvant candidate for mucosal vaccine development.” Reference: …